STRS Ohio’s Day One Biopharmaceuticals DAWN Stock Holding History

STRS Ohio’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$813K	Buy	37,900 +9,800	+35%	+$138K	﹤0.01%	781
2025 Q4	$262K	Buy	+28,100	New	+$235K	﹤0.01%	1399
2023 Q2	–	Sell	-2,300	Closed	-$30K	–	1982
2023 Q1	$30K	Buy	+2,300	New	+$44.9K	﹤0.01%	1834
2022 Q1	–	Sell	-2,500	Closed	-$42K	–	2157
2021 Q4	$42K	Hold	2,500	–	–	﹤0.01%	2024
2021 Q3	$59K	Buy	+2,500	New	+$59.9K	﹤0.01%	2044

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

STRS Ohio's DAWN Position: Q1 2026 in Review

STRS Ohio increased its Day One Biopharmaceuticals (DAWN) stake by 35% in Q1 2026, buying an estimated $138K and bringing the position to 37,900 shares worth $813K. The position accounts for ﹤0.01% of the portfolio, ranked #781.

STRS Ohio first reported a position in DAWN in Q3 2021 and has held it in 5 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

STRS Ohio held 37,900 shares of Day One Biopharmaceuticals worth $813K as of Q1 2026.
STRS Ohio bought 9,800 Day One Biopharmaceuticals shares in Q1 2026, an estimated $138K.
Day One Biopharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #781 holding.
STRS Ohio first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 5 quarters since.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.